Clinical Trials Browser

Phase 2 × selinexor × Thoracic × Clear all

NCT03193437 2023-02-16

SELECT

Phase 2 Terminated

8 enrolled 11 charts

Thymoma

NCT03466827 2018-03-15

TET-SEL

Phase 2 Unknown

Thymoma

NCT02351505 2016-05-16

Selinexor in Treating Patients With Relapsed Small Cell Lung Cancer

Phase 2 Terminated

1 enrolled 6 charts

Small Cell Lung Carcinoma